A C >t polymorphism located at position -1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women

Osteoporosis International

Volumn 19, Issue 8, 2008, Pages 1147-1152

  Pineda, B ^a   Laporta, P ^a   Hermenegildo, C ^a,b   Cano, A ^b   Garcia Perez M A ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Bone mass; CD40 gene; Kozak sequence; Osteopenia; Osteoporosis; Polymorphisms

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND;

ADULT; ARTICLE; BONE DENSITOMETRY; BONE MASS; FEMALE; FEMUR NECK; GENETIC RISK; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

AGED; ANTHROPOMETRY; ANTIGENS, CD40; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 46649097851     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0536-4     Document Type: Article

References (21)

1. Garcia-Perez MA (2006) Physiological regulation of bone metabolism and estrogen agonism. In: Cano A, Calaf i Alsina J, Dueñas-Díez JL (eds) Selective estrogen receptor modulators: a new brand of multitarget drugs. Springer, Berlin, pp 159-184
2. Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
3. Kong YY, Yoshida H, Sarosi I et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323
4. Dougall WC, Glaccum M, Charrier K et al (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412-2424
5. Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
6. Yun TJ, Tallquist MD, Aicher A et al (2001) Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 166:1482-1491
7. Roggia C, Gao Y, Cenci S et al (2001) Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 98:13960-13965
8. Cenci S, Weitzmann MN, Roggia C et al (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229-1237
9. Anderson DM, Maraskovsky E, Billingsley WL et al (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179
10. Takayanagi H, Ogasawara K, Hida S et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600-605
11. Sato T, Shibata T, Ikeda K et al (2001) Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 16:2215-2221
12. Kanematsu M, Sato T, Takai H et al (2000) Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 15:1321-1329
13. Farrugia AN, Atkins GJ, To LB et al (2003) Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Res 63:5438-5445
14. Li Y, Toraldo G, Li A et al (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109:3839-3848
15. Lopez-Granados E, Temmerman ST, Wu L et al (2007) Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis. Proc Natl Acad Sci U S A 104:5056-5061
16. Garcia-Perez MA, Moreno-Mercer J, Tarin JJ et al (2003) Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women. Maturitas 45:67-74
17. Garcia-Perez MA, Moreno-Mercer J, Tarin JJ et al (2004) Bone turnover markers and PTH levels in surgical versus natural menopause. Calcif Tissue Int 74:143-149
18. Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292
19. Jacobson EM, Concepcion E, Oashi T et al (2005) A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146:2684-2691
20. Schrum LW, Marriott I, Butler BR et al (2003) Functional CD40 expression induced following bacterial infection of mouse and human osteoblasts. Infect Immun 71:1209-1216
21. Ahuja SS, Zhao S, Bellido T et al (2003) CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144:1761-1769